Abstract
Purpose
Early detection and multidisciplinary treatment of colorectal liver metastases (CLM), preferably resection, can significantly prolong the survival of colorectal cancer patients. The purpose of this study was to analyze the incidence, management and long-term clinical outcome of CLM patients using data from a regional German tumour registry.
Methods
We conducted a retrospective analysis of 884 patients diagnosed with colorectal adenocarcinoma in the year 2002 and documented in a regional tumor registry in Southern Germany.
Results
Two hundred thirty-six patients (26.7%) had or developed CLM, 132 patients (14.9%) had synchronous CLM and 104 patients (11.8%) developed metachronous CLM. At diagnosis of CLM, 86 patients (36.4%) had 3 or less documented lesions, 6 patients (2.5%) had 4 to 6 lesions and 89 patients (37.7%) showed multiple, diffuse metastases; for 55 patients (23.3%), the number of lesions was not specified. CLM patients (19.1%) (5.1% of all patients) underwent liver resection; a higher resection rate (28.3%) was observed in a subgroup of patients treated in two academic centres. Patients without CLM had a significantly better 5-year survival rate than patients with liver metastases (65.5% versus 16.3%). CLM patients with up to 3 liver metastases (i.e., potentially resectable) who underwent liver resection (n=34) showed a significantly higher 5-year survival than non-resected (n=52) patients (40% versus 5%).
Conclusions
The present study is the first population-based analysis of the surgical management and outcome of CLM in Southern Germany. The percentage of liver resections was lower than expected, particularly for patients with three or less metastases. The present data suggest that relevant undertreatment of CLM patients may occur which may have a negative impact on survival.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Schmiegel W, Pox C, Reinacher-Schick A et al (2008) S3-Leitlinie Kolorektales Karzinom. Z Gastroenterol 46:1–73. doi:10.1055/s-2008-1027700
Donadon M, Ribero D, Morris-Stiff G, Abdalla EK, Vauthey JN (2007) New paradigm in the management of liver-only metastases from colorectal cancer. Gastrointest Cancer Res 1:20–27
Tomlinson JS, Jarnagin WR, DeMatteo RP et al (2007) Actual 10-year survival after resection of colorectal liver metastases defines cure. J Clin Oncol 25(29):4575–4580. doi:10.1200/JCO.2007.11.0833
Scheele J, Stangl R, Altendorf-Hofmann A (1990) Hepatic metastases from colorectal carcinoma: impact of surgical resection on the natural history. Br J Surg 77:1241–1246
Hurwitz H, Fehrenbacher L, Novotny W et al (2004) Bevacizumab plus irinotecan, fluorouracil, and leucovorin for metastatic colorectal cancer. N Engl J Med 350(23):2335–2342. doi:10.1056/NEJMoa032691
Venook A (2005) Critical evaluation of current treatments in metastatic colorectal cancer. Oncologist 10:250–261. doi:10.1634/theoncologist.10-4-250
Abdalla EK, Vauthey JN, Ellis LM et al (2004) Recurrence and outcomes following hepatic resection, radiofrequency ablation, and combined resection/ablation for colorectal liver metastases. Ann Surg 239(6):818–825
Abdalla EK, Adam R, Bilchik AJ, Jaeck D, Vauthey JN, Mahvi D (2006) Improving resectability of hepatic colorectal metastases: expert consensus statement. Ann Surg Oncol 13(10):1271–1280. doi:10.1245/s10434-006-9045-5
Shah SA, Haddad R, Al-Sukhni W et al (2006) Surgical resection of hepatic and pulmonary metastases from colorectal carcinoma. J Am Coll Surg 202(3):468–475. doi:10.1016/j.jamcollsurg.2005.11.008
Wei AC, Greig PD, Grant D, Taylor B, Langer B, Gallinger S (2006) Survival after hepatic resection for colorectal metastases: a 10-year experience. Ann Surg Oncol 13(5):668–676. doi:10.1245/ASO.2006.05.039
Jarnagin WR, Gonen M, Fong Y et al (2002) Improvement in perioperative outcome after hepatic resection: analysis of 1,803 consecutive cases over the past decade. Ann Surg 236(4):397–406. doi:10.1097/01.SLA.0000029003.66466.B3
Mantke R, Niepmann D, Gastinger I, Lippert H, Koch K, Quehl A (2006) Hepatic resections. Analysis of data from the Tumor Documentation Center in the state of Brandenburg, Germany, focusing on liver metastases of colorectal carcinoma. Chirurg 77(12):1135–1143. doi:10.1007/s00104-006-1247-7
Leporrier J, Maurel J, Chiche L, Bara S, Segol P, Launoy G (2006) A population-based study of the incidence, management and prognosis of hepatic metastases from colorectal cancer. Br J Surg 93(4):465–474. doi:10.1002/bjs.5278
Sjövall A, Järv V, Blomqvist L, Singnomklao T, Cedermark B, Glimelius B, Holm T (2004) The potential for improved outcome in patients with hepatic metastases from colon cancer: a population-based study. Eur J Surg Oncol 30(8):834–841. doi:10.1016/j.ejso.2004.06.010
Cummings LC, Payes JD, Cooper GS (2007) Survival after hepatic resection in metastatic colorectal cancer: a population-based study. Cancer 109(4):718–726. doi:10.1002/cncr.22448
Morris EJ, Forman D, Thomas JD, Quirke P, Taylor EF, Fairley L, Cottier B, Poston G (2010) Surgical management and outcomes of colorectal cancer liver metastases. Br J Surg 97:1110
Manfredi S, Lepage C, Hatem C, Coatmeur O, Faivre J, Bouvier AM (2006) Epidemiology and management of liver metastases from colorectal cancer. Ann Surg 244(2):254–259. doi:10.1097/01.sla.0000217629.94941.cf
Acknowledgements
The authors thank Dr. Chloe Milsom for editorial assistance and Prof. Dr. Ferdinand Hofstädter for critical revision of the manuscript.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Hackl, C., Gerken, M., Loss, M. et al. A population-based analysis on the rate and surgical management of colorectal liver metastases in Southern Germany. Int J Colorectal Dis 26, 1475–1481 (2011). https://doi.org/10.1007/s00384-011-1278-5
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00384-011-1278-5